Market Closed -
Other stock markets
|
Pre-market 08:30:02 am | |||
28.44 USD | +1.54% | 28.46 | +0.09% |
Financials (USD)
Sales 2024 * | 60.41B | Sales 2025 * | 62.71B | Capitalization | 161B |
---|---|---|---|---|---|
Net income 2024 * | 7.78B | Net income 2025 * | 11.29B | EV / Sales 2024 * | 3.63 x |
Net Debt 2024 * | 58.11B | Net Debt 2025 * | 49.97B | EV / Sales 2025 * | 3.37 x |
P/E ratio 2024 * |
19.8
x | P/E ratio 2025 * |
13.9
x | Employees | 88,000 |
Yield 2024 * |
5.87% | Yield 2025 * |
5.98% | Free-Float | 59.05% |
Latest transcript on Pfizer, Inc.
1 day | -0.84% | ||
1 week | +0.99% | ||
Current month | +11.01% | ||
1 month | +9.98% | ||
3 months | +5.45% | ||
6 months | -1.86% | ||
Current year | -1.22% |
Managers | Title | Age | Since |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 92-12-31 |
David Denton
DFI | Director of Finance/CFO | 59 | 22-05-01 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 20-03-31 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 17-02-22 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 13-09-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.74% | 254 M€ | +11.45% | - | |
9.37% | 17 M€ | +6.46% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 28.44 | +1.54% | 39,609,758 |
24-05-10 | 28.01 | -0.60% | 25,849,775 |
24-05-09 | 28.18 | -0.32% | 47,831,087 |
24-05-08 | 28.27 | +1.80% | 39,087,790 |
24-05-07 | 27.77 | -1.38% | 65,606,379 |
Delayed Quote Nyse, May 13, 2024 at 04:01 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.22% | 161B | |
+29.98% | 682B | |
+32.27% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.51% | 240B | |
+9.56% | 209B | |
-9.00% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- PFE Stock